Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 SNP-array and karyotype results of 15 fetuses with ROH

From: Chromosomal microarray analysis for prenatal diagnosis of uniparental disomy: a retrospective study

No

SNP-array (ROH)

Chromosome

Size (Mb)

Indications

Karyotype

Follow-up

1

arr[hg19] 6q13q14.1(71116171_83031752) × 2 hmz

6

12.0

High risk of serum screening

46,XY,inv(9)(p12q13)

Two-years-old growth and development is normal

2

arr[GRCh37] 6q14.1q15(79854364_89916843) × 2 hmz

6

10.0

Ultrasound soft marker

46,XY

one-year-old growth and development is normal

3

arr[GRCh37]6q22.31q23.2(123304566_134548143) × 2hmz (paternal UPD)

6

11.2

Thickened nuchal fold Agenesis of the corpus callosum; High risk of serum screening; High risk of neural tube defects

46,XY

TOP

4

arr[hg19] 7q31.2q32.1(115333496_128333758) × 2 hmz

7

13.0;12.7

Thickened nuchal translucency

46,XX

A female infant with normal external examination

5

arr[hg19] 7q33q36.3(137994712_157061474) × 2 hmz

7

19.1

First trimester medication history

46,XY

A male infant with normal external examination

6

arr[GRCh37]7q11.23q22.1(74069645_102039696) × 2 hmz (maternal UPD)

7

28.0

Both spouses have thalassemia

CVS karyotype:mos 47,XY, + 7[21]/46,XY,[44]; AF karyotype: 46,XY

TOP

7

arr[hg19] 11p13q13.3(32228901_69217423) × 2 hmz

11

37.0

High risk of serum screening

46,XY

A male infant with normal external examination

8

arr[GRCh37] 11q13.4q14.2(75162918_87295319) × 2 hmz (exclude UPD)

11

12.1

Advanced maternal age

46,XY

A male infant with normal external examination

9

arr[GRCh37] 11p15.1p14.1(18804524_30833779) × 2 hmz (exclude UPD)

11

12.0

Get a COVID-19 vaccine in the first trimester

46,XX

A female infant with normal external examination

10

arr[GRCh37] 11p15.5p15.1(230751_20060445) × 2 hmz

11

19.8

Thickened nuchal fold; ultrasound soft marker

46,XY

9 months old growth and development is normal

11

arr[GRCh37] 11p11.2q13.2(44287149_68239940) × 2 hmz

11

23.9

Both spouses are intellectual disability

46,XY

TOP

12

arr[GRCh37] 11p15.3p14.3(12110677_23047939) × 2 hmz

11

10.9

Thickened nuchal translucency; Pervious adverse pregnancies

46,XY

6 months old growth and development is normal

13

arr[GRCh37]14q11.2q32.33(20520198_107279475) × 2 hmz (paternal UPD)

14

Chromosome 14

Thickened nuchal fold; Agenesis of the corpus callosum

46,XY

TOP

14

arr[hg19] 15q21.1q22.2(48335576_60931242) × 2 hmz (exclude UPD)

15

12.6

Thickened nuchal translucency; Cardiac abnormalities

46,XX

TOP

15

arr[GRCh37] 20q11.21q12(29510307_40604830) × 2 hmz

20

11.1

Fetal bowel echo enhancement, left ventricular intense spot

46,XX

18 months old growth and development is normal

  1. TOP: termination of pregnancy
  2. Thickened nuchal translucency (NT): NT > 3.0 mm; Thickened nuchal fold (NF): NF > 6.0 mm